CDMO News
Dr. Reddy’s and Aurigene Partner with Kainomyx for New Anti-Malarial Drug
Dr. Reddy’s Laboratories Ltd. and its CRDMO arm Aurigene Pharmaceutical Services Ltd. have entered into a non-binding Memorandum of Understanding (MoU) with U.S.-based Kainomyx, Inc. to develop and commercialize a new anti-malarial drug. The collaboration seeks to address the global
22 August 2024
